News: Hydroxychloroquine doesn’t benefit... (NIH Research Matters) - Behind the headlines
In the news
Media coverage of health and science topics
Hydroxychloroquine doesn’t benefit hospitalized COVID-19 patients
In a final analysis of study data, researchers concluded that the medication hydroxychloroquine provides no benefit to adults hospitalized with COVID-19.
Read more at NIH Research Matters
Behind the headlines
Research findings and data from the National Library of Medicine
PubMed articles
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial
Among adults hospitalized with respiratory illness from COVID-19, treatment with hydroxychloroquine, compared with placebo, did not significantly improve clinical status …
Related content
Similar articles
Reviews
People also viewed
Also of interest
Additional recent and related news
Hydroxychloroquine does not benefit adults hospitalized with COVID-19
The trial began after lab studies and preliminary reports suggested that hydroxychloroquine might have promise in treating SARS-CoV-2.
Hydroxychloroquine studies show drug is not effective for early treatment of mild covid-19
The first randomized clinical trial of hydroxychlorquine for early treatment of patients with mild covid-19 showed the drug was not effective in treating the disease in patients who were not hospitalized. The study is a setback for proponents of the drug who argued it would be beneficial for …
Hydroxychloroquine Still Doesn’t Do Anything, New Data Shows
Two more studies prove that the much-hyped antimalarial doesn’t treat Covid-19.
The FDA Revokes Its Emergency Use Authorization for Hydroxychloroquine
So far, no studies have shown that the antimalarial drug can fight Covid-19, and agency officials say its potential benefits do not outweigh its risks.
WHO Halts Hydroxychloroquine Testing Over Safety Concerns
A paper published in The Lancet reported that hospitalized COVID-19 patients taking the drug had a higher risk of death, although some researchers have raised questions about the data.